Cargando…
Prediction of absolute risk of acute graft-versus-host disease following hematopoietic cell transplantation
Allogeneic hematopoietic cell transplantation (HCT) is the treatment of choice for a variety of hematologic malignancies and disorders. Unfortunately, acute graft-versus-host disease (GVHD) is a frequent complication of HCT. While substantial research has identified clinical, genetic and proteomic r...
Autores principales: | Lee, Catherine, Haneuse, Sebastien, Wang, Hai-Lin, Rose, Sherri, Spellman, Stephen R., Verneris, Michael, Hsu, Katharine C., Fleischhauer, Katharina, Lee, Stephanie J., Abdi, Reza |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5773230/ https://www.ncbi.nlm.nih.gov/pubmed/29346409 http://dx.doi.org/10.1371/journal.pone.0190610 |
Ejemplares similares
-
Donor-specific anti-HLA antibodies in unrelated hematopoietic cell transplantation for non-malignant disorders
por: Woolfrey, Ann, et al.
Publicado: (2018) -
No Association between Donor Telomere Length and Outcomes after Allogeneic Unrelated Hematopoietic Cell Transplant in Patients with Acute Leukemia
por: Gadalla, Shahinaz M., et al.
Publicado: (2017) -
Donor HLA-E Status Associates with Disease-Free Survival and Transplant-Related Mortality after Non In Vivo T Cell-Depleted HSCT for Acute Leukemia
por: Tsamadou, Chrysanthi, et al.
Publicado: (2019) -
Molecular Correlates of Socioeconomic Status and Clinical Outcomes Following Hematopoietic Cell Transplantation for Leukemia
por: Knight, Jennifer M, et al.
Publicado: (2019) -
Donor body mass index does not predict graft versus host disease following hematopoietic cell transplantation
por: Turcotte, Lucie M., et al.
Publicado: (2018)